The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly 17,000 ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Gene Therapy Market Share 2025 Increase in the prevalence of chronic disorders, rise in government support, and ethical acceptance of gene ...